Acknowledgements We thank the participants in this study
GLP-1 Medication FAQ Common side effects may include: Nausea Vomiting Constipation Diarrhoea Bloating Reflux Reduced appetite Fatigue Rare but more serious risks may include gallbladder issues, pancreatitis, dehydration, or worsening of certain pre-existing conditions
Strategies to optimize semaglutide results Several approaches can help maximize semaglutide effectiveness after switching from tirzepatide
Although both produce clinically meaningful results
Few clinical trials with human participants specifically look at if semaglutide causes thyroid C-cell tumors
It is indicated for adults with an initial BMI of 30 kg/m or greater, or 27 kg/m or greater in the presence of at least one weight-related comorbidity such as type 2 diabetes, hypertension, or obstructive sleep apnoea